SDSurabhi Dayal

Surabhi Dayal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Surabhi Dayal has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Priyadarshini Sahu

    Department of Dermatology Venereology and Leprology, Pt. B. D. Sharma University of Health Sciences Rohtak India

    11 shared publications
  • Priyadarshini Sahu

    Department of Telemedicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India

    4 shared publications
  • Lovleen Kaur

    Department of Dermatology, Venereology and Leprology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India

    3 shared publications
  • Vijay Kumar Jain

    Department of Dermatology, Venereology and Leprology, Pt. B. D. Sharma, Post Graduate Institute of Medical Sciences, Rohtak - Haryana, India

    3 shared publications
  • Ashish Amrani

    Senior Resident, Department of Dermatology, Venereology and Leprology, Pt B D Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India

    2 shared publications
  • Disha Chakraborty

    Department of Dermatology, Mayo Clinic, Rochester, USA

    2 shared publications

Latest Publications

  • Open Access

    TREATMENT OPTIMIZATION IN RECURRENT DERMATOPHYTOSIS: A PROSPECTIVE, RANDOMIZED, COMPARATIVE STUDY OF EXTENDED-DURATION VERSUS HIGH-DOSE TERBINAFINE AND ITRACONAZOLE

    by Rashi Singh, Savita Verma, Surabhi Dayal, Sapna Vashisth

    Objective: To compare efficacy and safety of terbinafine versus itraconazole administered in double dose and prolonged duration in patients with recurrent tinea corporis and cruris. Methods: This prospective, randomized study included 166 patients in four groups: A (terbinafine 250 mg once daily (OD), 4 w), B (terbinafine 500 mg OD, 2 w), C (itraconazole 100 mg twice daily (BD), 4 w), and D (itraconazole 200 mg BD, 2 w). Primary outcomes were clinical/mycological cure, global assessment, safety; secondary outcomes included quality of life, escape treatment, adherence. Significance was set at p<0.05. Results: Group C had highest efficacy (92.7% clinical cure and 100% mycological cure) with lowest recurrence. Liver Function Tests (LFTs) showed no significant abnormalities across all groups. No therapy discontinuations/serious Adverse Drug Reactions (ADRs) were reported. Dermatology Life Quality Index (DLQI) improved significantly from baseline to treatment end and 6 w post-treatment, indicating substantial and sustained improvement. Treatment compliance was high across all groups (≥90%), with no significant difference. Conclusion: Itraconazole 100 mg BD for 4 w was most effective, well-tolerated regimen, highlighting benefit of extended duration over increased dose in recurrent dermatophytosis.

  • Open Access

    Analyzing gaps in knowledge, attitude, and behavioral practices related to seborrhoeic dermatitis among medical undergraduate students

    by Rashi Singh, Savita Verma, Surabhi Dayal, Deepinder Narang

    Background: Seborrhoeic dermatitis (SD) is a prevalent, chronic, inflammatory skin condition, primarily affecting areas rich in sebaceous glands, yet awareness of its etiology, management, and associated psychosocial impact remains limited. This study aimed to assess the knowledge, attitudes, and practices (KAP) regarding seborrhoeic dermatitis among undergraduate medical students. Methods: A cross-sectional observational study was conducted from January to March 2024 at Pt. B. D. Sharma PGIMS, Rohtak, involving 379 medical undergraduates (aged 18–30). Data were collected via a structured, self-administered, expert-validated questionnaire covering general information, knowledge, attitudes, and practices regarding SD. Institutional Ethics Committee approval was obtained. Data were analyzed in Excel using descriptive statistics (mean±SD for continuous and percentages for categorical variables). Results: Among participants, 69.9% had experienced SD, with 48.5% currently affected. Knowledge gaps were evident: only 21.4% identified SD as a chronic inflammatory condition, and 28.5% recognized Malassezia as the cause. While fungal involvement was widely acknowledged, specific understanding was limited. Only 10.9% were satisfied with current treatments, and 48.2% believed oiling was beneficial, despite contrary evidence. Practices such as towel sharing (18.6%) and frequent scalp scratching (63.8%) were common, potentially worsening the condition. Conclusions: The study identified significant gaps in knowledge, attitudes, and practices regarding SD among medical undergraduates. Educational interventions targeting these gaps are necessary to improve awareness, debunk myths, and promote evidence-based management strategies for SD.


  • Open Access

    Lichenoid Pseudovesicular Papular Eruption on the Nose With Dermoscopic Features: A Case Series

    by Isha Gupta, Lovleen Kaur, Aanchal Bansal, Surabhi Dayal, Sanjay Kumar

    Citation: Gupta I, Kaur L, Bansal A, Dayal S, Kumar S. Lichenoid Pseudovesicular Papular Eruption on the Nose With Dermoscopic Features: A Case Series. Dermatol Pract Concept. 2023;13(4):e2023217. DOI: https://doi.org/10.5826/dpc.1304a217 Accepted: April 3, 2023; Published: October 2023 Copyright: ©2023 Gupta et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Aanchal Bansal, MBBS, Junior Resident, Department of Dermatology, Venereology and Leprology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India. Tel: +917086878303; Email: aanchal.bansal.ab125@gmail.com Keywords : LIPEN, lichenoid, dermoscopy, facial papules, pseudovesicles This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


  • Addisonian pigmentation associated with acute lymphoblastic leukemia: A rare paraneoplastic phenomenon

    by Mani Mehra, Meenakshi Sachdeva, Surabhi Dayal, Aanchal Gupta, Monica Deswal

    Addisonian pigmentation usually presents with nonspecific symptoms and signs, which are often ignored or misdiagnosed as a sign of other more common diseases. We present a case of 12-year-old child in whom diffuse Addisonian hyperpigmentation of skin was associated with underlying acute lymphoblastic leukemia (B-type), a rare paraneoplastic phenomenon in hematological malignancies.


  • Disseminated cysticercosis with multi‐system involvement in a child

    by Lovleen Kaur, Aanchal Bansal, Surabhi Dayal, Ambar Karwal, Sunita Singh

    We report a rare case of disseminated cysticercosis in a 7-year-old Indian girl with recent onset seizures treated with antiepileptics for 2 months. When she presented to dermatology clinic, she had multifocal subcutaneous and submucosal nodules. The subsequent diagnostic workup revealed extensive neurocysticercosis as well as orbital and myocysticercosis.

  • Open Access

    Various Color Presentations of Pseudochromhidrosis—A Case Series

    by Priyadarshini Sahu, Disha Chakraborty, Surabhi Dayal, Meenakshi Sachdeva

    Citation: Sahu P, Chakraborty D, Dayal S, Sachdeva M. Various Colors of Presentation of Pseudochromhidrosis - A Case Series. Dermatol Pract Concept. 2023;13(1):e2023028. DOI: https://doi.org/10.5826/dpc.1301a28 Accepted: June 8, 2022; Published: January 2023 Copyright: ©2023 Sahu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Priyadarshini Sahu, Department of Dermatology, Venereology and Leprosy, Pt. B. D. Sharma, University of Health Sciences, Rohtak, 1075, First floor, Adarsh Nagar, Rohtak, Haryana, India. Pin-124001 Tel: +91-9416536159 E-mail: priyadarshini.sahu.9@gmail.com Keywords : Pseudochromhidrosis, red, black, pink This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


  • Open Access

    Subcutaneous Granuloma Annulare in an Atypical Age Group in Immediate Post-COVID Phase

    by Lovleen Kaur, Disha Chakraborty, Surabhi Dayal, Sunita Singh, Karamvir Yadav

    Citation: Kaur L, Chakraborty D, Dayal S, Singh S, Yadav K. Subcutaneous Granuloma Annulare in an atypical age group in immediate post-covid phase. Dermatol Pract Concept. 2022;12(4):e2022156. DOI: https://doi.org/10.5826/dpc.1204a156 Accepted: January 7, 2022; Published: October 2022 Copyright: ©2022 Kaur et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Lovleen Kaur, MD, Senior Resident, Department of Dermatology, Venereology and Leprology, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India. Tel: +917888661584; Email: dr.lovleen555@gmail.com Keywords : Granuloma Annulare, Covid-19, SARS-Cov-2, Palisading granuloma, Subcutaneous GA This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


  • Efficacy of Microneedling With 35% Glycolic Acid Peels Versus Microneedling With 15% Trichloroacetic Acid Peels in Treatment of Atrophic Acne Scars: A Randomized Controlled Trial

    by Surabhi Dayal, Rupinder Kaur, Priyadarshini Md Sahu

    BACKGROUND: Combination of microneedling and chemical peeling is a simple cost-effective treatment for acne scars. OBJECTIVE: To compare efficacy and safety of combining microneedling with 35% glycolic acid (GA) peel versus microneedling with 15% trichloroacetic acid (TCA) peel in facial atrophic acne scars. METHODS: Forty acne scars patients were randomly divided into 2 groups of 20 each. Patients underwent microneedling followed by 35% GA peeling in Group 1 and 15% TCA peeling in Group 2 at 2 weekly intervals. Improvement was graded by Goodman and Baron's qualitative and quantitative global acne scar grading systems, physician's global assessment, and visual analogue scale (VAS). Skin texture was graded by VAS. RESULTS: On comparing qualitative and quantitative acne scar grading within groups, there was significant difference from the baseline. When the two groups were compared for quantitative and qualitative acne scar grading, the difference was statistically not significant at the end of therapy. In VAS, greater number of patients assessed response as excellent and good in Group 1 than in Group 2 indicating better skin texture improvement in Group 1. CONCLUSION: Both combinations were equally efficacious in treating acne scars. Glycolic acid peel delivered additional advantage of improvement in skin texture.


  • Scrutinising the role of simvastatin in a patient of Pachyonychia Congenita with KRT6A gene mutation

    by Shruti Sharma, Surabhi Dayal, Kamal Aggarwal, Varsha Gowda V.M, Rupinder Kaur

    A 25‐year‐old male patient presented with palmoplantar keratoderma, dystrophic nails, severe plantar pain and oral leukokeratosis since birth. On genetic analysis, a heterozygous KRT6A gene missense mutation (c.1381G > A, p.Glu461Lys in exon 7) was identified by next‐generation sequencing technology, consistent with pachyonychia congenita 6a. Oral simvastatin 40 mg was started once daily, and after 16 weeks of therapy, excellent improvement was noted in palmoplantar keratoderma and plantar pain. The maximum thickness of his foot callosity reduced by 4 mm on ultrasonography, and the Dermatology Life Quality Index score dropped significantly by eight points. These benefits may be attributed to inhibition of KRT6A gene expression, modulation of autophagy and mitophagy and Keap1‐Nrf2 signalling activation; the latter two mechanisms of statins previously undiscussed in the context of pachyonychia congenita. Simvastatin and other statins are pathogenesis‐targeted, disease‐modifying therapy in pachyonychia congenita, therefore qualifying as a promising treatment avenue and warranting further clinical trials.